Scientists have used breast cancer cells’ weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
Alvotech’s BLA for Stelara biosimilar rejected by FDa
The regulator pointed out deficiencies at the manufacturing facility. Credit: Gorodenkoff/Shutterstock.com. The US Food and Drug Administration (FDA) has rejected Alvotech’s biologics licence application (BLA)
October 13, 2023